Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Petrelli

Showing results (31-40 of 348) with videos related to

Pageof 35
Sort By:
JAMA Oncology|June 26, 2020
Risk-Benefit Comparisons Between Shorter and Longer Durations of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer-ReplyAlberto Zaniboni, Fausto Petrelli, Roberto Labianca
Medical Oncology (Northwood, London, England)|April 26, 2011
5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trialsFausto Petrelli, Mary Cabiddu, Sandro Barni
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Adjuvant nivolumab for gastric and gastro-oesophageal junction cancerFausto Petrelli, Andrea Celotti, Lorenzo Dottorini
Critical Reviews in Oncology/Hematology|June 18, 2026
Anticancer Drug Dosing: Balancing Benefit and ToxicityFausto Petrelli, Andrea D'Alessio, Lorenzo Dottorini
The Lancet. Oncology|December 3, 2014
FOLFIRI with cetuximab or bevacizumab: FIRE-3Fausto Petrelli, Andrea Coinu, Sandro Barni
Tumori|October 22, 2021
Curative treatments for colon cancer during the COVID-19 pandemic eraFausto Petrelli, Roberto Labianca, Alberto Zaniboni
Journal of Geriatric Oncology|September 11, 2023
Prognostic relevance of sidedness in older patients with colon cancer: A review and pooled analysis of 227,218 patientsFausto Petrelli, Lorenzo Dottorini, Andrea Luciani
European Journal of Cancer (Oxford, England : 1990)|September 28, 2023
10 years or less of extended adjuvant endocrine therapy for postmenopausal breast cancer patients: A systematic review and network meta-analysisFausto Petrelli, Matteo Cavallone, Lorenzo Dottorini
Current Treatment Options in Oncology|May 26, 2018
Right Versus Left Colon Cancer: Resectable and Metastatic DiseaseMichele Ghidini, Fausto Petrelli, Gianluca Tomasello
Expert Review of Anticancer Therapy|February 6, 2010
Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfallsSandro Barni, Mary Cabiddu, Fausto Petrelli
Pageof 35

Showing results (31-40 of 348) with videos related to

Sort By:
Pageof 35
JAMA Oncology|June 26, 2020
Risk-Benefit Comparisons Between Shorter and Longer Durations of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer-ReplyAlberto Zaniboni, Fausto Petrelli, Roberto Labianca
Medical Oncology (Northwood, London, England)|April 26, 2011
5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trialsFausto Petrelli, Mary Cabiddu, Sandro Barni
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Adjuvant nivolumab for gastric and gastro-oesophageal junction cancerFausto Petrelli, Andrea Celotti, Lorenzo Dottorini
Critical Reviews in Oncology/Hematology|June 18, 2026
Anticancer Drug Dosing: Balancing Benefit and ToxicityFausto Petrelli, Andrea D'Alessio, Lorenzo Dottorini
The Lancet. Oncology|December 3, 2014
FOLFIRI with cetuximab or bevacizumab: FIRE-3Fausto Petrelli, Andrea Coinu, Sandro Barni
Tumori|October 22, 2021
Curative treatments for colon cancer during the COVID-19 pandemic eraFausto Petrelli, Roberto Labianca, Alberto Zaniboni
Journal of Geriatric Oncology|September 11, 2023
Prognostic relevance of sidedness in older patients with colon cancer: A review and pooled analysis of 227,218 patientsFausto Petrelli, Lorenzo Dottorini, Andrea Luciani
European Journal of Cancer (Oxford, England : 1990)|September 28, 2023
10 years or less of extended adjuvant endocrine therapy for postmenopausal breast cancer patients: A systematic review and network meta-analysisFausto Petrelli, Matteo Cavallone, Lorenzo Dottorini
Current Treatment Options in Oncology|May 26, 2018
Right Versus Left Colon Cancer: Resectable and Metastatic DiseaseMichele Ghidini, Fausto Petrelli, Gianluca Tomasello
Expert Review of Anticancer Therapy|February 6, 2010
Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfallsSandro Barni, Mary Cabiddu, Fausto Petrelli
Pageof 35